Stock News
Uncovering the Truth: Debunking the Short Report on Super Micro Computer
Uncovering the Truth: Debunking the Short Report on Super Micro Computer Description I reiterate a ‘Buy’ rating for Super Micro Computer, despite the Hindenburg short report, with a one-year price target of $700 per share. Super Micro’s past accounting violations are acknowledged but resolved; current related-party transactions are fully disclosed and not fundamentally problematic. The…
Breaking News: AITX’s RAD Secures 32-Unit RIO Expansion Order from Major Client!
Welcome to the World of AI Security Towers! An Exciting Expansion Order Wow, did you hear the news? Artificial Intelligence Technology Solutions, Inc. (AITX) just announced a major expansion order for 32 RIO 360 solar-powered security towers! This order comes from an existing client and is a huge win for the company. Talk about impressive…
Unlocking the Secret to Surviving Mondays: A Guide to Making it Through the Week with a Smile
Welcome to the Nevada Lithium Summit September 29-30, 2024 at Hyatt Regency Lake Tahoe Resort, Incline Village, Nevada RENO, NV / ACCESSWIRE / September 26, 2024 / M2i Global, Inc. (“M2i,” the “Company,” “we,” “our” or “us”) (OTCQB:MTWO), a company specializing in the development and execution of a complete global value supply chain for critical…
Unleashing Hope: Longboard Pharmaceuticals Begins Groundbreaking Phase 3 DEEp-SEA Trial for Bexicaserin in Dravet Syndrome
Unleashing Hope: Longboard Pharmaceuticals Begins Groundbreaking Phase 3 DEEp-SEA Trial for Bexicaserin in Dravet Syndrome Description: LA JOLLA, Calif.–(BUSINESS WIRE)—- $LBPH #Epilepsy–Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that it has initiated its global Phase 3 DEEp SEA Study evaluating its investigational…
Breaking Down the Numbers: Interim Results for the First Half of 2024
Biodexa Pharmaceuticals PLC Interim Results June 30, 2024 Operational Highlights Biodexa Pharmaceuticals PLC, a clinical stage biopharmaceutical company, announces unaudited interim results for the six months ended June 30, 2024. The Company secured exclusive worldwide licensing of eRapa™, a Phase 3 ready asset targeting Familial Adenomatous Polyposis (“FAP”), along with access to a $17 million…
Boosting National Preparedness: Emergent BioSolutions Secures $67.4 Million Contract for Additional TEMBEXA (brincidofovir)
Boosting National Preparedness: Emergent BioSolutions Secures $67.4 Million Contract for Additional TEMBEXA (brincidofovir) GAITHERSBURG, Md., Sept. 26, 2024 (GLOBE NEWSWIRE) Eager to protect the nation from potential bioterrorism threats and outbreaks of infectious diseases, Emergent BioSolutions Inc. has recently secured a significant contract aimed at bolstering national preparedness. The $67.4 million contract will provide additional…
Unlocking the Power of Access: A Comprehensive Guide to Navigating the AccessWire Platform
South Pacific Metals Corp. Announces DTC Eligibility and Marketing Agreements Introduction South Pacific Metals Corp. (TSXV:SPMC)(FSE:6J00)(OTCQB:SPMEF), a leading gold-copper exploration company operating in Papua New Guinea, has exciting news to share with its investors and the market. The Company’s common shares are now eligible for electronic clearing and settlement in the United States through the…
Get Ready for Some Stock Action: Fairfax Financial Holdings Limited Plans to Buy Back Shares!
Get Ready for Some Stock Action: Fairfax Financial Holdings Limited Plans to Buy Back Shares! TORONTO, Sept. 26, 2024 (GLOBE NEWSWIRE) — Fairfax Financial Holdings Limited (“Fairfax”) (TSX: FFH and FFH.U) announces that the Toronto Stock Exchange (the “TSX”) has accepted a notice filed by Fairfax of its intention to commence a Normal Course Issuer…